Fig. 3
The 10-year cumulative incidences of secondary malignant neoplasms were 2.2 and 7.6% in the low risk (LR) and high risk (HR) groups, respectively
Fig. 3 | BMC Cancer
The 10-year cumulative incidences of secondary malignant neoplasms were 2.2 and 7.6% in the low risk (LR) and high risk (HR) groups, respectively